Privia Health Group, Inc. (NASDAQ:PRVA) EVP Sells $41,481.84 in Stock

Privia Health Group, Inc. (NASDAQ:PRVA) EVP Thomas Bartrum sold 2,252 shares of the company’s stock in a transaction on Tuesday, April 30th. The stock was sold at an average price of $18.42, for a total transaction of $41,481.84. Following the completion of the transaction, the executive vice president now directly owns 103,862 shares of the company’s stock, valued at approximately $1,913,138.04. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website.

Privia Health Group Price Performance

Shares of PRVA stock opened at $18.74 on Friday. The company has a market cap of $2.22 billion, a PE ratio of 98.64, a price-to-earnings-growth ratio of 2.56 and a beta of 0.81. Privia Health Group, Inc. has a 1 year low of $17.54 and a 1 year high of $30.15. The stock’s 50 day simple moving average is $19.62 and its two-hundred day simple moving average is $21.12.

Privia Health Group (NASDAQ:PRVA) last released its quarterly earnings results on Tuesday, February 27th. The company reported $0.02 earnings per share for the quarter, missing the consensus estimate of $0.04 by ($0.02). The company had revenue of $440.80 million for the quarter, compared to analysts’ expectations of $425.81 million. Privia Health Group had a net margin of 1.39% and a return on equity of 3.97%. The business’s quarterly revenue was up 21.0% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.14 EPS. Equities research analysts expect that Privia Health Group, Inc. will post 0.26 EPS for the current year.

Hedge Funds Weigh In On Privia Health Group

A number of large investors have recently made changes to their positions in the company. Covestor Ltd lifted its stake in Privia Health Group by 8.3% in the third quarter. Covestor Ltd now owns 6,703 shares of the company’s stock worth $154,000 after purchasing an additional 514 shares during the last quarter. Yousif Capital Management LLC raised its holdings in shares of Privia Health Group by 1.1% in the fourth quarter. Yousif Capital Management LLC now owns 52,628 shares of the company’s stock worth $1,212,000 after buying an additional 563 shares during the period. New York State Common Retirement Fund lifted its stake in shares of Privia Health Group by 2.7% during the 3rd quarter. New York State Common Retirement Fund now owns 27,966 shares of the company’s stock worth $643,000 after acquiring an additional 737 shares during the last quarter. Allspring Global Investments Holdings LLC boosted its holdings in Privia Health Group by 9.2% during the 1st quarter. Allspring Global Investments Holdings LLC now owns 8,970 shares of the company’s stock valued at $176,000 after acquiring an additional 756 shares during the period. Finally, Glenmede Trust Co. NA grew its position in Privia Health Group by 0.9% in the 3rd quarter. Glenmede Trust Co. NA now owns 107,711 shares of the company’s stock valued at $2,477,000 after acquiring an additional 976 shares during the last quarter. 94.48% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of research firms have recently weighed in on PRVA. Evercore ISI dropped their price objective on Privia Health Group from $26.00 to $25.00 and set an “outperform” rating for the company in a research note on Wednesday, February 28th. Truist Financial dropped their price target on Privia Health Group from $32.00 to $28.00 and set a “buy” rating for the company in a research note on Thursday, February 29th. Jefferies Financial Group began coverage on shares of Privia Health Group in a research report on Monday, February 26th. They set a “buy” rating and a $25.00 price objective on the stock. Bank of America lowered shares of Privia Health Group from a “buy” rating to a “neutral” rating and dropped their target price for the stock from $27.00 to $21.00 in a research report on Thursday, February 22nd. Finally, Canaccord Genuity Group reduced their price target on shares of Privia Health Group from $41.00 to $37.00 and set a “buy” rating on the stock in a report on Tuesday, March 19th. Two analysts have rated the stock with a hold rating and ten have given a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $27.62.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.